Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Post by fringelifeon May 12, 2017 9:38pm
217 Views
Post# 26239922

THC Biomed still being overlooked why?

THC Biomed still being overlooked why?Chris Parry's latest article claims to have the top 5 undervalued weed stocks and not one mention of THC Biomed. Instead he mentions companies with already over $200 million market caps, like as if that's really undervalued. Yeah right, try $60 million market cap, lowest market cap of all the fully licensed companies.

Not sure how much to trust Chris Parry's advice anymore though. The same guy who got a lot of people to put their money into Finore Mining, only to see their investments dive when the deal fell apart. Most of his "advice" is often after the fact. So when an undervalued stock finally starts gaining some value, then he might mention it but by then it's too late for those who wanted to get a good value. When THC Biomed goes on a run to over a dollar, watch as he writes an article about how THC finally gaining traction... except thanks for not telling your readers about THC under 60 cents you idiot. He calls himself a guru, but he really sucks at making good predictions it seems. Anybody can write an article about the next rising star, but try writing one before it takes off... oh and his weed stock predictions don't count because all of them are at a higher value than last year at this time. I know he loves to brag about his prediction on Supreme, which I was able to figure out in 2015 before I really knew who Chris Parry was.

Anyway, sorry about the rant, but seeing Chris Parry's article and recent talks with other investors frustrates me why THC is never mentioned as a value play. It's as if they don't even exist when people love to mention companies like Beleave with an even higher market cap and yet a year away from a sales license.
Bullboard Posts